Brinker Capital Investments’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,697
Closed -$114K 1579
2022
Q4
$114K Buy
10,697
+38
+0.4% +$442 ﹤0.01% 1309
2022
Q3
$111K Buy
10,659
+243
+2% +$3.17K ﹤0.01% 1301
2022
Q2
$131K Buy
+10,416
New +$111K ﹤0.01% 1319
2019
Q3
Sell
-300
Closed -$1K 790
2019
Q2
$1K Buy
+300
New +$1.74K ﹤0.01% 899

Other funds holding DVAX

Brinker Capital Investments's DVAX Position: Q1 2023 in Review

Brinker Capital Investments sold out of Dynavax Technologies (DVAX) in Q1 2023, closing a stake of 10,697 shares — an estimated $114K sold.

Brinker Capital Investments first reported a position in DVAX in Q2 2019 and held it in 4 quarters. The position peaked at $131K in Q2 2022. 216 funds tracked by Wall St. Rank hold DVAX as of Q1 2023.

  • Brinker Capital Investments reported no remaining Dynavax Technologies position as of Q1 2023 after selling out during the quarter.
  • Brinker Capital Investments sold 10,697 Dynavax Technologies shares in Q1 2023, an estimated $114K.
  • Brinker Capital Investments first reported a position in Dynavax Technologies in Q2 2019 and held it in 4 quarters.
  • Brinker Capital Investments's Dynavax Technologies position peaked at $131K in Q2 2022.
  • 216 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2023.

Based on Brinker Capital Investments's 13F filing for Q1 2023, filed 31 Jul 2025.